<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The ATM serine-threonine kinase plays a central role in the cellular response to DNA damage </plain></SENT>
<SENT sid="1" pm="."><plain>Germ-line mutations in the ATM gene cause <z:hpo ids='HP_0001251'>ataxia</z:hpo>-<z:hpo ids='HP_0001009'>telangiectasia</z:hpo> (A-T), a <z:e sem="disease" ids="C0559758" disease_type="Disease or Syndrome" abbrv="">multisystem disorder</z:e> associated with predisposition to <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Moreover, somatic ATM mutations have been identified in T-cell prolymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and B-cell <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, the entire ATM coding sequence was examined in genomic DNA from 120 lymphoid <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Novel mutations and mutations implicated in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and/or A-T were found in 9 of 45 diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCLs</z:e>), 2 of 24 follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and 1 of 27 adult <z:hpo ids='HP_0006721'>acute lymphoblastic leukemias</z:hpo>, whereas no such mutations were detected among 24 peripheral T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The mutational spectrum consisted of 2 nonsense mutations, 1 mutation affecting <z:chebi fb="40" ids="33697">RNA</z:chebi> splicing, and 10 missense variants </plain></SENT>
<SENT sid="6" pm="."><plain>Most of these mutations were associated with loss or mutation of the paired ATM allele, consistent with biallelic inactivation of ATM </plain></SENT>
<SENT sid="7" pm="."><plain>Of the 9 DLBCLs with ATM mutations, 7 also carried TP53 mutations and/or deletions of the INK4a/ARF locus (P =.003) </plain></SENT>
<SENT sid="8" pm="."><plain>The ATM 735C&gt;T substitution previously considered a rare <z:mpath ids='MPATH_458'>normal</z:mpath> variant was found to be 5.6 times more frequent in individuals with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> than in random individuals (P =.026), suggesting that it may predispose to B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Our data suggest that ATM mutations contribute to the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, and that ATM and the ARF-p53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor pathway may cooperate in the pathogenesis of this <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
</text></document>